AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 14 filers reported holding AVENUE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 279,898 | $326,081 | 0.28% |
| SHIKIAR ASSET MANAGEMENT INC | 10,000 | $12 | 0.00% |
| EMFO, LLC | 533 | $621 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,564 | $5,317 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,430 | $13,373 | 0.00% |
| BlackRock Inc. | 1,942 | $2,263 | 0.00% |
| Bank of New York Mellon Corp | 53,363 | $62,168 | 0.00% |
| BARRETT & COMPANY, INC. | 15 | $17 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,022 | $9 | 0.00% |
| MORGAN STANLEY | 414 | $482 | 0.00% |
| STATE STREET CORP | 30,593 | $35,794 | 0.00% |
| Renaissance Technologies | 15,982 | $19 | 0.00% |
| ROYAL BANK OF CANADA | 55 | $0 | 0.00% |
This page lists AVENUE THERAPEUTICS INC's shareholders in Q1 2023. To view AVENUE THERAPEUTICS INC's shareholder history, click here.